192 filings
Page 3 of 10
8-K
bh0o4jl ye8b6gia55
20 Nov 23
Departure of Directors or Certain Officers
5:08pm
8-K
yx3m2q5
9 Nov 23
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:03am
8-K
l4h8sm29b8m0af
30 Oct 23
Results of Operations and Financial Condition
4:14pm
EFFECT
987a ia4ex7torcc3
17 Oct 23
Notice of effectiveness
12:15am
CORRESP
qcg5je6
12 Oct 23
Correspondence with SEC
12:00am
PRE 14A
cfondx
6 Oct 23
Preliminary proxy
4:15pm
UPLOAD
qwh4s79uuq fafzvm
22 Aug 23
Letter from SEC
12:00am
D
wsmajhnoy44nrw i9ql7
11 Aug 23
$2.11 mm in equity, sold $2.11 mm, 10 investors
4:01pm
424B5
yd7dwsmydj2i2
9 Aug 23
Prospectus supplement for primary offering
4:37pm
8-K
u5z54f97co1d 5mp1881
9 Aug 23
Better Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:07pm
8-K
xf3kgk 1021kid
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
424B5
lxmf9q3q1v772gn
26 Jul 23
Prospectus supplement for primary offering
5:04pm
8-K
vumk7b ym8vd9i
12 Jul 23
Better Therapeutics Receives FDA Authorization for AspyreRxTM to Treat Adults with Type 2 Diabetes
12:00am